vs
Orthofix Medical Inc.（OFIX）与Summit Midstream Corp（SMC）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Summit Midstream Corp的1.5倍（$219.9M vs $142.3M），Orthofix Medical Inc.净利率更高（-1.0% vs -5.1%，领先4.1%），Summit Midstream Corp自由现金流更多（$34.5M vs $16.8M）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Summit Midstream Corp是一家北美中游能源企业，为上游油气生产商提供天然气与原油收集管道、压缩设施及采出水处理等基础设施服务，运营资产主要分布于美国多个核心陆上油气资源盆地。
OFIX vs SMC — 直观对比
营收规模更大
OFIX
是对方的1.5倍
$142.3M
净利率更高
OFIX
高出4.1%
-5.1%
自由现金流更多
SMC
多$17.7M
$16.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $142.3M |
| 净利润 | $-2.2M | $-7.3M |
| 毛利率 | 71.1% | 72.1% |
| 营业利润率 | 0.2% | -5.5% |
| 净利率 | -1.0% | -5.1% |
| 营收同比 | 2.0% | — |
| 净利润同比 | 92.4% | — |
| 每股收益（稀释后） | $-0.05 | $-0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXSMC
| Q4 25 | $219.9M | $142.3M | ||
| Q3 25 | $205.6M | $146.9M | ||
| Q2 25 | $203.1M | $140.2M | ||
| Q1 25 | $193.6M | $132.7M | ||
| Q4 24 | $215.7M | — | ||
| Q3 24 | $196.6M | $102.4M | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $188.6M | — |
净利润OFIXSMC
| Q4 25 | $-2.2M | $-7.3M | ||
| Q3 25 | $-22.8M | $-1.6M | ||
| Q2 25 | $-14.1M | $-8.0M | ||
| Q1 25 | $-53.1M | $2.0M | ||
| Q4 24 | $-29.1M | — | ||
| Q3 24 | $-27.4M | $-204.9M | ||
| Q2 24 | $-33.4M | — | ||
| Q1 24 | $-36.0M | — |
毛利率OFIXSMC
| Q4 25 | 71.1% | 72.1% | ||
| Q3 25 | 72.2% | 74.0% | ||
| Q2 25 | 68.7% | 74.4% | ||
| Q1 25 | 62.8% | 73.3% | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 68.7% | 72.4% | ||
| Q2 24 | 67.8% | — | ||
| Q1 24 | 67.5% | — |
营业利润率OFIXSMC
| Q4 25 | 0.2% | -5.5% | ||
| Q3 25 | -8.3% | 3.8% | ||
| Q2 25 | -7.9% | -3.6% | ||
| Q1 25 | -25.2% | 3.7% | ||
| Q4 24 | -5.3% | — | ||
| Q3 24 | -9.6% | -53.7% | ||
| Q2 24 | -12.5% | — | ||
| Q1 24 | -15.6% | — |
净利率OFIXSMC
| Q4 25 | -1.0% | -5.1% | ||
| Q3 25 | -11.1% | -1.1% | ||
| Q2 25 | -6.9% | -5.7% | ||
| Q1 25 | -27.4% | 1.5% | ||
| Q4 24 | -13.5% | — | ||
| Q3 24 | -13.9% | -200.1% | ||
| Q2 24 | -16.8% | — | ||
| Q1 24 | -19.1% | — |
每股收益（稀释后）OFIXSMC
| Q4 25 | $-0.05 | $-0.66 | ||
| Q3 25 | $-0.57 | $-0.13 | ||
| Q2 25 | $-0.36 | $-0.66 | ||
| Q1 25 | $-1.35 | $-0.16 | ||
| Q4 24 | $-0.76 | — | ||
| Q3 24 | $-0.71 | $-19.25 | ||
| Q2 24 | $-0.88 | — | ||
| Q1 24 | $-0.95 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $9.3M |
| 总债务越低越好 | — | $1.0B |
| 股东权益账面价值 | $450.0M | $546.2M |
| 总资产 | $850.6M | $2.4B |
| 负债/权益比越低杠杆越低 | — | 1.91× |
8季度趋势，按日历期对齐
现金及短期投资OFIXSMC
| Q4 25 | $82.0M | $9.3M | ||
| Q3 25 | $62.9M | $24.6M | ||
| Q2 25 | $65.6M | $20.9M | ||
| Q1 25 | $58.0M | $26.2M | ||
| Q4 24 | $83.2M | — | ||
| Q3 24 | $30.1M | $17.8M | ||
| Q2 24 | $26.4M | — | ||
| Q1 24 | $27.0M | — |
总债务OFIXSMC
| Q4 25 | — | $1.0B | ||
| Q3 25 | $157.2M | $1.1B | ||
| Q2 25 | $157.0M | $1.1B | ||
| Q1 25 | $156.9M | $1.1B | ||
| Q4 24 | $157.0M | — | ||
| Q3 24 | $118.5M | $957.0M | ||
| Q2 24 | $118.0M | — | ||
| Q1 24 | $118.2M | — |
股东权益OFIXSMC
| Q4 25 | $450.0M | $546.2M | ||
| Q3 25 | $442.5M | $551.9M | ||
| Q2 25 | $458.3M | $552.0M | ||
| Q1 25 | $458.3M | $558.1M | ||
| Q4 24 | $503.1M | — | ||
| Q3 24 | $525.9M | $651.5M | ||
| Q2 24 | $546.0M | — | ||
| Q1 24 | $570.3M | — |
总资产OFIXSMC
| Q4 25 | $850.6M | $2.4B | ||
| Q3 25 | $832.6M | $2.4B | ||
| Q2 25 | $837.2M | $2.4B | ||
| Q1 25 | $823.1M | $2.4B | ||
| Q4 24 | $893.3M | — | ||
| Q3 24 | $867.9M | $2.0B | ||
| Q2 24 | $882.0M | — | ||
| Q1 24 | $906.0M | — |
负债/权益比OFIXSMC
| Q4 25 | — | 1.91× | ||
| Q3 25 | 0.36× | 1.96× | ||
| Q2 25 | 0.34× | 1.95× | ||
| Q1 25 | 0.34× | 1.94× | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | 1.47× | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $53.7M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $34.5M |
| 自由现金流率自由现金流/营收 | 7.6% | 24.3% |
| 资本支出强度资本支出/营收 | 4.9% | 13.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $44.6M |
8季度趋势，按日历期对齐
经营现金流OFIXSMC
| Q4 25 | $27.7M | $53.7M | ||
| Q3 25 | $12.4M | $26.7M | ||
| Q2 25 | $11.6M | $37.2M | ||
| Q1 25 | $-18.4M | $16.0M | ||
| Q4 24 | $23.7M | — | ||
| Q3 24 | $11.7M | — | ||
| Q2 24 | $9.0M | — | ||
| Q1 24 | $-18.6M | — |
自由现金流OFIXSMC
| Q4 25 | $16.8M | $34.5M | ||
| Q3 25 | $2.5M | $3.8M | ||
| Q2 25 | $4.5M | $10.8M | ||
| Q1 25 | $-25.1M | $-4.6M | ||
| Q4 24 | $15.2M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $-360.0K | — | ||
| Q1 24 | $-29.1M | — |
自由现金流率OFIXSMC
| Q4 25 | 7.6% | 24.3% | ||
| Q3 25 | 1.2% | 2.6% | ||
| Q2 25 | 2.2% | 7.7% | ||
| Q1 25 | -13.0% | -3.4% | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | -0.2% | — | ||
| Q1 24 | -15.4% | — |
资本支出强度OFIXSMC
| Q4 25 | 4.9% | 13.4% | ||
| Q3 25 | 4.8% | 15.6% | ||
| Q2 25 | 3.5% | 18.8% | ||
| Q1 25 | 3.5% | 15.5% | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 4.7% | — | ||
| Q1 24 | 5.6% | — |
现金转化率OFIXSMC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 7.89× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
SMC
| Rockies Segment | $86.2M | 61% |
| Mid Con Barnett Shale Segment | $39.4M | 28% |
| Piceance Basin Segment | $15.8M | 11% |
